Bronchoalveolar lavage in drug-induced lung disease

Clinics in Chest Medicine

Volumn 25, Issue 1, 2004, Pages 25-35

  Costabel, Ulrich ^a   Uzaslan, Esra ^b   Guzman, Josune ^c  

^a RUHRLANDKLINIK   (Germany)

^b ULUDAG UNIVERSITY   (Turkey)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMIODARONE; AMPHOTERICIN B; AMPICILLIN; ATENOLOL; AZATHIOPRINE; BLEOMYCIN; BUSULFAN; CELIPROLOL; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOTHIAZIDE; CYTOTOXIC AGENT; ETOPOSIDE; FLECAINIDE; GOLD; MALOPRIM; METHOTREXATE; MINOCYCLINE; NILUTAMIDE; NITROFURANTOIN; PENICILLAMINE; PENICILLIN G; PHENYTOIN; PROPRANOLOL; SALAZOSULFAPYRIDINE; TETRACYCLINE; TRYPTOPHAN; UNINDEXED DRUG; VINCRISTINE;

ALLERGIC PNEUMONITIS; ASBESTOSIS; BACTERIAL PNEUMONIA; BERYLLIOSIS; BRONCHIOLITIS; BRONCHOPULMONARY ASPERGILLOMA; BRONCHOSCOPY; CHURG STRAUSS SYNDROME; CONNECTIVE TISSUE DISEASE; CROHN DISEASE; CYTOLOGY; DIAGNOSTIC APPROACH ROUTE; DRUG CYTOTOXICITY; DRUG INDUCED DISEASE; EOSINOPHILIA; FIBROSING ALVEOLITIS; HISTIOCYTOSIS X; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPEREOSINOPHILIC SYNDROME; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LOEFFLER PNEUMONIA; LUNG ALVEOLUS PROTEINOSIS; LUNG DISEASE; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG HEMOSIDEROSIS; LUNG LAVAGE; LYMPHOCYTOSIS; MALIGNANT NEOPLASTIC DISEASE; MIXED CONNECTIVE TISSUE DISEASE; NEUTROPHILIA; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; SARCOIDOSIS; SILICOSIS; TUBERCULOSIS; VIRUS PNEUMONIA; WEGENER GRANULOMATOSIS;

BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; DIAGNOSIS, DIFFERENTIAL; HUMANS; IATROGENIC DISEASE; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL;

EID: 1542302728     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(03)00143-6     Document Type: Review

References (106)

1. Reynolds HY, Newball HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974;84:559-73.
2. Yeager HC, Williams MC, Beckman JF, et al. Sarcoidosis: analysis of cells obtained by bronchial lavage. Am Rev Respir Dis 1976;113:96-100.
3. Crystal RG, Roberts WG, Hunninghake GW, et al. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med 1981;94:73-94.
4. Klech H, Hutter C, editors. Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Force on BAL. Eur Respir J 1990;3:937-74.
5. American Thoracic Society. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis 1990;142:481-6.
6. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001;7:255-61.
7. Guzman J, Costabel U. Bronchoalveolar lavage in diagnostic cytology. In: Wied GL, Keebler CM, Koss LG, Patten SF, Rosenthal DL, editors. Compendium on diagnostic cytology. Chicago: Tutorials of Cytology; 1992. p. 251-65.
8. Reynolds HY. Use of bronchoalveolar lavage in humans: past necessity and future imperative. Lung 2000;178:271-93.
9. Klech H, Pohl W, editors. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the ERS Task Group. Eur Respir J 1989;2:561-85.
10. Hunninghake GW, Kawanami O, Ferrans VJ, et al. Characterisation of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 1981;123:407-12.
11. Abe S, Munakata M, Nishimura M, et al. Gallium-67 scintigraphy, bronchoalveolar lavage, and pathologic changes in patients with pulmonary sarcoidosis. Chest 1984;85:650-5.
12. Semenzato G, Chilosi M, Ossi E, et al. Bronchoalveolar lavage and lung histology: comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis. Am Rev Respir Dis 1985;132:400-4.
13. Campbell DA, Poulter LW, duBois RM. Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis. Am Rev Respir Dis 1985;132:1300-6.
14. Paradis IL, Dauber JH, Rabin BS. Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986;133:855-60.
15. BAL Cooperative Steering Group. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990;141:S169-202.
16. Haslam PL, Baughman RP, editors. Report of European Respiratory Society (ERS) Task Force: guidelines for measurement of acellular components and recommmendations for standardization of bronchoalveolar lavage (BAL). Eur Respir Rev 1999;9:25-157.
17. Lam S, Leriche JC, Kijek K, et al. Effect of bronchial lavage volume on cellular and protein recovery. Chest 1985;88:856-9.
18. Baughman RP. Bronchoalveolar lavage. 1st edition. St. Louis (MO): Mosby Year Book; 1992.
19. Costabel U. CD4/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis? Eur Respir J 1997;10:2699-700.
20. Costabel U, Bross KJ, Baur R, et al. Zellzahl, Differentialzytologie und Lymphozytensubpopulationen der bronchoalveolären Lavage unter verschiedenen Aufbewahrungsbedingungen [Cell number differentials and lymphocyte subsets in BAL under different storage]. Prax Klin Pneumol 1988;42:103-5.
21. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999;14:245-8.
22. Maier KL, Leuschel L, Costabel U. Increased oxidized methionine residues in BAL fluid proteins in acute or chronic bronchitis. Eur Respir J 1992;5:651-8.
23. Costabel U, Guzman J. Effect of smoking on bronchoalveolar lavage constituents. Eur Respir J 1992;5:776-9.
24. Costabel U. Atlas of bronchoalveolar lavage. London: Chapman and Hall; 1998.
25. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG Statement on Sarcoidosis. Sarc Vasc Diffuse Lung Dis 1999;16:149-73.
26. ATS/ERS Statement. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000;161:646-64.
27. Huang MS, Colby T, Goellner JR, et al. Utility of broncholveolar lavage in the diagnosis of drug-induced pulmonary toxicity. Acta Cytol 1989;33:533-8.
28. Israel-Biet D, Venet A, Caubarrere I, et al. Bronchoalveolar lavage in amiodarone pneumonitis. Cellular abnormalities and their relevance to pathogenesis. Chest 1987;91:214-21.
29. White DA, Kris MG, Stover DE. Bronchoalveolar lavage cell populations in bleomycin lung toxicity. Thorax 1987;42:551-2.
30. Schnabel A, Richter C, Bauerfeind S, et al. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax 1997;52:377-9.
31. White DA, Rankin JA, Stover DE, et al. Methotrexate pneumonitis. Am Rev Respir Dis 1989;139:18-21.
32. Akoun G, Mayaud C, Touboul JL, et al. Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease. Thorax 1987;42:652-5.
33. Israel-Biet D, Danel C, Costabel U, et al. The clinical role of BAL in drug induced pneumonitis. Eur Respir Rev 1992;2:97-9.
34. Kudeken N, Kawakami K, Kakazu T, et al. [A case of acetaminophen-induced pneumonitis]. Nihon Kyobu Shikkan Gakkai Zasshi 1993;31: 1585-90 [in Japanese].
35. Shimizu K, Shiota S, Nakaya Y, et al. [Bufferin-induced lung injury manifesting as acute eosinophilic pneumonia]. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:1099-1103. [in Japanese].
36. Uchida K, Sekiguchi S, Matsuda K, et al. [Acute eosinophilic pneumonia associated with aspirin]. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:873-7.
37. Coudert B, Bailly F, Lombard JN, et al. Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature. Chest 1992;102:1005-12.
38. Ohar JA, Jackson F, Dettenmeier PA, et al. Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis. Chest 1992;102:999-1004.
39. Akoun GM, Cadranel JL, Blanchette G, et al. Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients. Chest 1991;99:1177-82.
40. Noh H, Lee YK, Kan SW, et al. Acute eosinophilic pneumonia associated with amitriptyline in a hemodialysis patient. Yonsei Med J 2001;42:357-9.
41. Miyashita N, Nakajima M, Kuroki M, et al. [Sulbactam/ampicillin-induced pneumonitis]. Nihon Kokyuki Gakkai Zasshi 1998;36:684-9 [in Japanese].
42. Refabert L, Sinnassamy P, Leroy B, et al. Azathioprine-induced pulmonary haemorrhage in a child after renal transplantation. Pediatr Nephrol 1995;9:470-3.
43. Doshi AV, Desai D, Bhaduri A, et al. Lymphocytic interstitial pneumonitis associated with autoimmune hepatitis. Indian J Gastroenterol 2001;20:76-7.
44. Gali JM, Vilanova JL, Mayos M, et al. Febarbamateinduced pulmonary eosinophilia: a case report. Respiration (Herrlisheim) 1986;49(3):231-4.
45. Naoki K, Yamaguchi K, Soejima K, et al. [A case of interstitial pneumonia induced by intravesical administration of bacillus Calmette-Guerin (BCG)]. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:1383-8 [in Japanese].
46. Akoun GM, Cadranel JL, Milleron BJ, et al. Bronchoalveolar lavage cell data in 19 patients with drugassociated pneumonitis (except amiodarone). Chest 1991;99:98-104.
47. Pfitzenmeyer P, Foucher P, Dennewald G, et al. Pleuropulmonary changes induced by ergoline drugs. Eur Respir J 1996;9:1013-9.
48. Kishimoto N, Fujii K. [A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis]. Nihon Kokyuki Gakkai Zasshi 2002;40:321-5 [in Japanese].
49. Hara A, Sakamoto O, Matsumoto M, et al. [A case of bucillamine-induced interstitial pneumonia]. Nihon Kyobu Shikkan Gakkai Zasshi 1992;30:1743-8 [in Japanese].
50. Vergnon JM, Boucheron S, Riffat J, et al. [Interstitial pneumopathies caused by busulfan. Histologic, developmental and bronchoalveolar lavage analysis of 3 cases]. Rev Med Interne 1988;9:377-83 [in French].
51. Fernandez Alvarez R, Gullon Blanco JA, Riesgo Alonso C, et al. [Acute pulmonary toxicity caused by carbamazepine: apropos of a case]. Arch Bronconeumol 1994;30:471-2.
52. Ben Jemaa M, Kammoun S, Kanoun F, et al. [Respiratory manifestations of carbamazepine. Apropos of a case]. Rev Pneumol Clin 1997;53:351-4 [in French].
53. Wilschut FA, Cobben NA, Thunnissen FB, et al. Recurrent respiratory distress associated with carbamazepine overdose. Eur Respir J 1997;10:2163-5.
54. Lombard JN, Bonnotte B, Maynadie M, et al. Celiprolol pneumonitis. Eur Respir J 1993;6:588-91.
55. Crestani B, Jaccard A, Israel-Biet D, et al. Chlorambucil-associated pneumonitis. Chest 1994;105:634-6.
56. Mitja K, Izidor K, Music E. [Chloroquine-induced drug hypersensitivity alveolitis]. Pneumologie 2000;54:395-7 [in German].
57. Hashizume T, Numata H, Matsushita K. [Drug-induced pneumonitis caused by sulfamethoxazole-trimethoprim]. Nihon Kokyuki Gakkai Zasshi 2001;39:664-7 [in Japanese].
58. Usui Y, Aida H, Kimula Y, et al. A case of cyclophosphamide-induced interstitial pneumonitis diagnosed by bronchoalveolar lavage. Respiration (Herrlisheim) 1992;59:125-8.
59. Kheir A, Chabot F, Lesur O, et al. [Fibrosing pneumopathy induced by cyclothiazide. Apropos of a case]. Rev Mal Respir 1992;9:208-12 [in French].
60. + lymphocytic pneumonitis in a patient receiving cyproterone acetate. South Med J 1997;90:1048-9.
61. Yamamoto Y, Narasaki F, Futsuki Y, et al. Disopyramide-induced pneumonitis, diagnosed by lymphocyte stimulation test using bronchoalveolar lavage fluid. Intern Med 2001;40:775-8.
62. Hatakeyama S, Tachibana A, Morita M, et al. [Etoposide-induced pneumonitis]. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:210-4 [in Japanese].
63. Pesenti S, Lauque D, Daste G, et al. Diffuse infiltrative lung disease associated with flecainide. Report of two cases. Respiration (Herrlisheim) 2002;69:182-5.
64. Tomioka R, King Jr TE. Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 1997;155:1011-20.
65. Okuda Y, Takasugi K, Imai A, et al. [A case of rheumatoid arthritis complicated with auranofin-induced acute interstitial pneumonitis]. Ryumachi 1991;31:54-61 [in Japanese].
66. Brander PE, Tukiainen P. Acute eosinophilic pneumonia in a heroin smoker. Eur Respir J 1993;6:750-2.
67. Ogata K, Koga T, Yagawa K. Interferon-related bronchiolitis obliterans organizing pneumonia. Chest 1994;106:612-3.
68. Kourakata H, Tanabe Y, Mikami O, et al. [A case of interferon beta-induced pneumonia]. Nihon Kokyuki Gakkai Zasshi 2000;38:687-91 [in Japanese].
69. Hashizume T, Numata H. [A case of eosinophilic pneumonia possibly due to ifenprodil]. Nihon Kokyuki Gakkai Zasshi 2001;39:868-70 [in Japanese].
70. Oishi Y, Sando Y, Tajima S, et al. Indomethacin induced bulky lymphadenopathy and eosinophilic pneumonia. Respirology 2001;6:57-60.
71. Hatakeyama S, Tatibana A, Suzuki K, et al. [Isoniazid-induced pneumonitis]. Nihon Kokyuki Gakkai Zasshi 1998;36:448-52 [in Japanese].
72. Fujimori K, Shimatsu Y, Suzuki E, et al. [Levofloxacin-induced eosinophilic pneumonia complicated by bronchial asthma]. Nihon Kokyuki Gakkai Zasshi 2000;38:385- 90 [in Japanese].
73. Ii T, Doutsu Y, Ashitani J, et al. [A case of loxoprofeninduced pulmonary eosinophilia]. Nihon Kyobu Shikkan Gakkai Zasshi 1992;30: 926-9 [in Japanese].
74. Begbie S, Burgess KR. Maloprim-induced pulmonary eosinophilia. Chest 1993;103:305-6.
75. Liote H, Gauthier JF, Prier A, et al. [Acute, reversible, interstitial pneumopathy induced by melphalan]. Rev Mal Respir 1989;6:461- 4 [in French].
76. Fuhrman C, Parrot A, Wislez M, et al. Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis. Am J Respir Crit Care Med 2001;164:1186-91.
77. Bando T, Fujimura M, Noda Y, et al. Minocyclineinduced pneumonitis with bilateral hilar lymphadenopathy and pleural effusion. Intern Med 1994;33:177-9.
78. Sitbon O, Bidel N, Dussopt C, et al. Minocycline pneumonitis and eosinophilia. A report on eight patients. Arch Intern Med 1994;154:1633-40.
79. Lenci G, Muller-Quernheim J, Lorenz J, et al. [Toxic lung damage caused by mitomycin C]. Pneumologie 1994;48:197-201 [in German].
80. Dan M, Aderka D, Topilsky M, et al. Hypersensitivity pneumonitis induced by nalidixic acid. Arch Intern Med 1986;146:1423-4.
81. Pfitzenmeyer P, Foucher P, Piard F, et al. Nilutamide pneumonitis: a report on eight patients. Thorax 1992;47:622-7.
82. Akoun GM, Liote HA, Liote F, et al. Provocation test coupled with bronchoalveolar lavage in diagnosis of drug (nilutamide)-induced hypersensitivity pneumonitis. Chest 1990;97:495-8.
83. Brutinel WM, Martin II WJ. Chronic nitrofurantoin reaction associated with T-lymphocyte alveolitis. Chest 1986;89:150-2.
84. Lena H, Desrues B, Le Coz A, et al. Severe diffuse interstitial pneumonitis induced by carmustine (BCNU). Chest 1994;105:1602-3.
85. Gagnadoux F, Roiron C, Carrie E, et al. Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer. Am J Clin Oncol 2002;25:388-90.
86. Trisolini R, Lazzari Agli L, Tassinari D, et al. Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy. Eur Respir J 2001;18:243-5.
87. Fujimori K, Yokoyama A, Kurita Y, et al. Paclitaxelinduced cell-mediated hypersensitivity pneumonitis. Diagnosis using leukocyte migration test, bronchoalveolar lavage and transbronchial lung biopsy. Oncology 1998;55:340-4.
88. Inoue M, Tanigawa S, Masutani M, et al. [A case of piperacillin-induced pneumonitis] Nihon Kyobu Shikkan Gakkai Zasshi 1993;31:530-3 [in Japanese].
89. Chamberlain DW, Hyland RH, Ross DJ. Diphenylhydantoin-induced lymphocytic interstitial pneumonia. Chest 1986;90:458-60.
90. Munn NJ, Baughman RP, Ploysongsang Y, et al. Bronchoalveolar lavage in acute drug-hypersensitivity pneumonitis probably caused by phenytoin. South Med J 1984;77:1594-6.
91. Fujimori K, Shimatsu Y, Suzuki E, et al. [Pranoprofen-induced lung injury manifesting as acute eosinophilic pneumonia]. Nihon Kokyuki Gakkai Zasshi 1999;37:401-5 [in Japanese].
92. Goldberg SK, Lipschutz JB, Ricketts RM, et al. Procainamide-induced lupus lung disease characterized by neutrophil alveolitis. Am J Med 1984;76:146-50.
93. Akoun GM, Milleron BJ, Mayaud CM, et al. Provocation test coupled with bronchoalveolar lavage in diagnosis of propranolol-induced hypersensitivity pneumonitis. Am Rev Respir Dis 1989;139:247-9.
94. Kunichika N, Miyahara N, Kotani K, et al. Pneumonitis induced by rifampicin. Thorax 2002;57:1000-1.
95. Sasaki S, Kawanami R, Motizuki Y, et al. [Serrapeptase-induced lung injury manifesting as acute eosiniphilic pneumonia]. Nihon Kokyuki Gakkai Zasshi 2000;38:540-4 [in Japanese].
96. Hirahara K, Saitoh T, Terada I, et al. [A case of pneumonitis due to serrapeptase]. Nihon Kyobu Shikkan Gakkai Zasshi 1989;27:1231-6 [in Japanese].
97. Morelon E, Stern M, Israel-Biet D, et al. Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation 2001;72:787-90.
98. Valcke Y, Pauwels R, Van der Straeten M. Bronchoalveolar lavage in acute hypersensitivity pneumonitis caused by sulfasalazine. Chest 1987;92:572-3.
99. Nakatsumi Y, Nomura M, Yasui M, et al. [A case of eosinophilic pneumonia due to tolfenamic acid]. Nihon Kyobu Shikkan Gakkai Zasshi 1993;31:1322-6 [in Japanese].
100. Kimura N, Miyazaki E, Matsuno O, et al. [Drug-induced pneumonitis with eosinophilic infiltration due to tosufloxacin tosilate] Nihon Kokyuki Gakkai Zasshi 1998;36:618-22 [in Japanese].
101. Salerno SM, Strong JS, Roth BJ, et al. Eosinophilic pneumonia and respiratory failure associated with a trazodone overdose. Am J Respir Crit Care Med 1995;152:2170-2.
102. Bogaerts Y, Van Renterghem D, Vanvuchelen J, et al. Interstitial pneumonitis and pulmonary vasculitis in a patient taking an L-tryptophan preparation. Eur Respir J 1991;4:1033-6.
103. Camus P. Drug induced infiltrative lung diseases. In: Schwarz MI, King TE, editors. Interstitial lung disease. 4th edition. London: BC Decker; 2003. p. 485-534.
104. Costabel U, Teschler H, Guzman J. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 1992;5:791-7.
105. Bonaccorsi A, Cancellieri A, Chilosi M, et al. Acute interstitial pneumonia: report of a series. Eur Respir J 2003;21:187-91.
106. Semenzato G, Poletti V. Bronchoalveolar lavage in lung cancer. Respiration (Herrlisheim) 1992;59(Suppl 1):44-6.